Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer [Phase 2, Phase 3]

View source ↗

Summary

This entry notes that results from a phase 2/3 trial of melatonin for fatigue and other symptoms in patients with advanced cancer have been completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Cancer, Fatigue | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-04-20